Reader-supported. We may earn a commission when you use our partner links. How we’re funded

Our take

Lumora is worth considering for a discussion before payment, provided the resulting quote specifies ongoing care and renewal costs.

Request visit, medication, lab and follow-up totalsCurrent supply-option prices require confirmation
Subcutaneous injectionFormat offered
Prescription requiredSubject to clinical evaluation

What stands out

  • No-card initial assessment advertised
  • Evidence described as mixed
  • Separate treatment-unavailability terms published

What to weigh

  • No complete current public quote established
  • Processed charges generally described as nonrefundable
  • State and supply options require confirmation

An assessment can precede the financial commitment

Lumora advertises a free initial assessment without requiring a card and says the complete pricing is shown before commitment. That is a useful entry point for someone who wants to discuss whether care makes sense before accepting a prescription plan. It should not be read as a promise that every later clinical service is free.

Ask what the initial assessment includes and when a paid evaluation begins. If additional records or testing are recommended, obtain those costs before proceeding. The strongest version of this process leaves you with a clear recommendation and a written quote that you can consider without rushing into recurring billing.

The public selector did not establish a current price

The sermorelin page identifies subcutaneous injection and invites the reader to select a supply option. During this review, the public text showed the options loading rather than displaying their prices. The offer itself is verified, but a current complete plan total was not established.

Request the actual supply period, prescription quantity, initial charge and renewal amount. Include laboratory work and follow-up visits, which the site says will be disclosed before commitment. Avoid carrying an older price from another review into this decision. A fresh itemized quote is more useful than a price estimate based on a different patient’s formulation or term.

The evidence label deserves a substantive conversation

Lumora labels the evidence for this offering as mixed. That is a helpful qualification alongside its more optimistic descriptions of wellness goals. It should open a discussion about uncertainty rather than function as a small disclaimer beneath a predetermined treatment recommendation.

Ask which evidence applies to the proposed preparation and your reason for seeking care. The page recommends baseline IGF-1 and metabolic evaluation; the clinician should explain what tests would change a decision in your case. Our laboratory guide offers questions to bring to that discussion. A result by itself should not be treated as an automatic reason to prescribe.

Recurring care has separate cancellation rules

Lumora’s terms say some plans renew automatically at the checkout interval and can be canceled before the next billing date. They generally describe processed charges as nonrefundable. The ability to pause or stop treatment clinically therefore does not by itself explain what happens to an order already processed.

Ask how a clinical change affects future payments and medication that has not yet shipped. Save the selected billing interval and the cancellation confirmation. If choosing a longer prepaid option, establish the complete exposure before payment rather than assuming that a monthly equivalent means you can recover every unused month at that same rate.

Unavailability is addressed separately

The terms describe possible prorated refunds for an unshipped portion of prepaid treatment when the prescribed option becomes unavailable. They also describe discussing an alternative, a refund or a credit. That is useful to know, but it is a conditional policy rather than a guarantee of uninterrupted access to a particular medication.

Lumora may suit someone who values an assessment before payment and wants the uncertainty discussed openly. Confirm the pharmacy, state access and complete quote first. This review reflects public materials checked in October 2026, without personal treatment experience. Compounded sermorelin is not FDA-approved, and a flexible care description does not establish expected results.

Common questions

Is Lumora’s assessment free?

Its product page advertises a free start without a card. That does not establish that later clinical visits, medication or testing are free.

How much is its sermorelin plan?

The public selector did not expose current supply prices. The page says visits, medication, labs and follow-up pricing is disclosed before commitment.

What if treatment becomes unavailable?

The terms describe possible prorated refunds for unshipped prepaid treatment and the option to discuss an alternative. Eligibility and the accepted plan terms need confirmation.

Research behind the decision

Explore Lumora MD

See the current offer and decide whether you want to start a consultation.

Visit Lumora MD

Reader-supported. We may earn a commission when you use our partner links. How we’re funded

Sources & further reading

Provider prices and terms may change.

  1. Lumora MD website
  2. FDA: Understanding the risks of compounded drugs
  3. Endocrine Society: Hormones and Aging scientific statement